Decreasing Medication Does Not Equal More Risks for People with Rheumatoid Arthritis in Remission
Saturday, November 10, 2012 - 18:30
in Health & Medicine
Extending the time between doses, or tapering, TNF-inhibitor drugs in people with rheumatoid arthritis in remission can be done in some patients without significantly increasing disease activity or impairing joint function, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C.